Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand
Guest Editor:
John Paul Tomtishen III, Director of Manufacturing, Technical Operations at Legend Biotech Co.
John Paul Tomtishen III
Director of Manufacturing, Technical Operations at Legend Biotech Co.
November 2020
Sponsors
Co-sponsor
Download full spotlight
Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing
S Snykers
16 February 2021
Webinars on Demand: Expert Commentary
Read more
Streamlining and optimizing viral vector bioprocess and analytical development
J Tarnowski,
N Kotsopoulou,
K Patel
et al.
19 January 2021
Expert Roundtable
Read more
Abbreviated in-house qualification of real time mycoplasma detection kit
S Viswanathan
7 January 2021
On Demand Webinar
Read more
Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing
S Snykers
7 January 2021
On Demand Webinar
Read more
Streamlining and optimizing viral vector bioprocess and analytical development
J Tarnowski,
N Kotsopoulou,
K Patel
et al.
22 December 2020
Expert Roundtable Video
Watch now
Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand
J Tomtishen III
1 December 2020
Foreword
Read more
De-risking the final formulation, fill and finish step in cell therapy manufacturing: considerations for an automated solution
D Sethi,
A Cunningham
26 November 2020
Innovator Insight
Read more
Measurement: the central nervous system of a quality manufacturing line for tissue engineering and regenerative medicine products
M McCorry,
B Robinson-Zeigler,
R McFarland
et al.
25 November 2020
Expert Insight
Read more
A cell therapy media fill protocol for validation of aseptic processing of cord blood
F DeDino,
K Vincent,
D DiNello
et al.
24 November 2020
Methodology Paper
Read more
Addressing pain points in iPSC-derived cell therapy manufacture and scale-up
B Marques
24 November 2020
Interview
Read more
Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges
L Raviv
23 November 2020
Interview
Read more
The role of flow cytometry in advanced therapy medicinal products
T Nastos
20 November 2020
Expert Insight
Read more
γδ T cell therapy: devising a manufacturing-friendly bioprocess
S O'Farrell
17 November 2020
Interview
Read more
Challenges & trends in stem cell-derived extracellular vesicle bioprocessing
J Escobar Ivirico
12 November 2020
Interview
Read more
Limiting variability to achieve reproducibility in cell manufacturing
A Lamontagne,
A Fesnak
11 November 2020
Expert Insight
Read more
Process development: how to win the race in cell & gene therapy
R Baghirzade
4 November 2020
Editorial
Read more
The right time to move to an automated manufacturing system like the Cocoon platform: the when, the why, and the how
Matt Hewitt, PhD, Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
Donna Rill, Chief Technology Officer at Triumvira Immunologics Inc
3 December 2020
Webinar
Watch now
Focus on allogeneic CAR-Ts manufacturing challenges and solutions
Marcos Langtry, Head of Allogeneic Cell Therapy Commercial Development, Lonza Pharma & Biotech
Alex Sargent, Scientist at Lonza Pharma & Biotech
Behnam Baghbaderani, Global Head, Process Development, Emerging Technologies at Lonza Pharma & Biotech
5 November 2020
Webinar
Watch now
×
Please enter your email to register
Register